STOUGHTON, Mass., Nov. 26, 2019 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. COLL, a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that management will participate in the following investor conferences in December:
- The Piper Jaffray 31st Annual Healthcare Conference on Tuesday, December 3rd in New York City. Management will present at 2:30 p.m. ET and will also participate in investor meetings.
- The Jefferies Biopharma Summit on Thursday, December 12th in Denver. Management will participate in investor meetings.
About Collegium Pharmaceutical, Inc.
Collegium is a specialty pharmaceutical company committed to being the leader in responsible pain management. Collegium's headquarters are located in Stoughton, Massachusetts. For more information, please visit the company's website at www.collegiumpharma.com.
Contact:
Alex Dasalla
adasalla@collegiumpharma.com
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
